The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits – all of which are promoting awareness and demand for clinical nutrition solutions.
STUDY ASSUMPTION YEARS
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
CLINICAL NUTRITION MARKET KEY TAKEAWAYS
- Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.
- Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.
- Oral administration leads the route segment due to convenience, safety, and broad acceptance.
- Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.
- Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.
- Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.
MARKET GROWTH FACTORS
- Role of Nutrition in Chronic Disease (Diabetes, Cancer, Osteoporosis) Management
The importance of nutrition in managing chronic diseases is a major factor propelling the clinical nutrition market forward. With the global rise in chronic conditions such as diabetes, cancer, and osteoporosis, coupled with an aging population, there’s a growing need for specialized nutritional products and services designed for these specific health challenges. This demand for therapeutic formulas, supplements, and customized nutritional support aims to enhance patient outcomes and overall quality of life. It’s also encouraging innovation among clinical nutrition manufacturers, who are developing new products and integrated digital services, including personalized dietary plans and telehealth solutions, to cater to these intricate patient needs. As healthcare systems increasingly acknowledge the cost-effectiveness of nutritional therapy in both prevention and management, it boosts investment and demand, ultimately driving the growth of the clinical nutrition market.
- Identifying Malnutrition Risk and Nutrient Deficiencies
Timely and accurate identification of malnutrition risk and nutrient deficiencies significantly boosts the clinical nutrition market by creating a clear, evidence-based pathway from diagnosis to intervention. This process directly drives demand for specialized clinical nutrition products, such as oral nutritional supplements (ONS), medical foods, and parenteral/enteral nutrition, and for professional services, including nutritional assessments and counseling. Standardized malnutrition screening tools like MUST, NRS-2002, and MNA enable early detection in hospitals, long-term care facilities, and outpatient settings. This proactive approach expands the market by preventing disease progression, reducing comorbidities and hospital readmissions, shortening hospital stays, and demonstrating the cost-effectiveness of nutritional support in improving patient outcomes. Additionally, growing awareness among healthcare providers and patients about the link between nutrition and disease management fuels the demand for targeted, personalized nutritional solutions, driving innovation in product development and digital health services.
- Growing Medical Nutrition Therapy (MNT) Market & Increasing Adoption of Metabolomics in Dietary Management
The growing Medical Nutrition Therapy (MNT) market, paired with the rising use of metabolomics, is really shaking things up in the clinical nutrition world. It’s pushing us toward more evidence-based, data-driven, and personalized nutritional solutions. As MNT gets more recognition for its effectiveness and cost savings in managing chronic conditions like diabetes and cancer, we’re seeing a strong demand for specialized clinical nutrition products and services. Metabolomics plays a crucial role here, acting as a tech booster that helps clinical nutrition manufacturers and providers move away from the old “one-size-fits-all” methods. Instead, they can now offer a precise, real-time look at an individual’s metabolic state, which leads to truly tailored dietary interventions. This powerful combination paves the way for innovative, targeted medical foods, supplements, and digital health platforms that not only improve patient outcomes but also enhance compliance and tap into a more sophisticated, high-value market segment.
Request for a sample copy of this report:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
- Infant Nutrition: addresses dietary needs of newborns with formula and supplements
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
- Oral
- Enteral
- Parenteral
Breakup by Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Breakup by End User:
- Pediatric
- Adults
- Geriatric
Breakup by Region:
-
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS
Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.
RECENT DEVELOPMENTS & NEWS
Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.
KEY PLAYERS
Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Mainframe Market: https://www.imarcgroup.com/mainframe-market
Transthyretin Amyloidosis Treatment Market: https://www.imarcgroup.com/transthyretin-amyloidosis-treatment-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
